Fungal meningitis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 21: Line 21:
*[[Neurodevelopmental Disorders|Neurodevelopmental]] delays in children
*[[Neurodevelopmental Disorders|Neurodevelopmental]] delays in children
====Complications from therapy====
====Complications from therapy====
Treatment of [[fungal meningitis]] in [[Human Immunodeficiency Virus (HIV)|HIV]]-infected patients receiving [[HIV AIDS medical therapy|HAART]], organ transplantation, and pregnancy may result in [[immune reconstitution syndrome]].<ref name="pmid17521592">{{cite journal| author=Singh N, Perfect JR| title=Immune reconstitution syndrome associated with opportunistic mycoses. | journal=Lancet Infect Dis | year= 2007 | volume= 7 | issue= 6 | pages= 395-401 | pmid=17521592 | doi=10.1016/S1473-3099(07)70085-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17521592  }} </ref><ref name="pmid12471589">{{cite journal| author=Jenny-Avital ER, Abadi M| title=Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. | journal=Clin Infect Dis | year= 2002 | volume= 35 | issue= 12 | pages= e128-33 | pmid=12471589 | doi=10.1086/344467 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12471589  }} </ref><ref name="pmid10225395">{{cite journal| author=Blanche P, Gombert B, Ginsburg C, Passeron A, Stubei I, Rigolet A et al.| title=HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy. | journal=Scand J Infect Dis | year= 1998 | volume= 30 | issue= 6 | pages= 615-6 | pmid=10225395 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10225395  }} </ref><ref name="pmid9727570">{{cite journal| author=Woods ML, MacGinley R, Eisen DP, Allworth AM| title=HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. | journal=AIDS | year= 1998 | volume= 12 | issue= 12 | pages= 1491-4 | pmid=9727570 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9727570  }} </ref>
Treatment of [[fungal meningitis]] in [[Human Immunodeficiency Virus (HIV)|HIV]]-infected patients receiving [[HIV AIDS medical therapy|HAART]], [[organ transplantation]], and [[pregnancy]] may result in [[immune reconstitution syndrome]].<ref name="pmid17521592">{{cite journal| author=Singh N, Perfect JR| title=Immune reconstitution syndrome associated with opportunistic mycoses. | journal=Lancet Infect Dis | year= 2007 | volume= 7 | issue= 6 | pages= 395-401 | pmid=17521592 | doi=10.1016/S1473-3099(07)70085-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17521592  }} </ref><ref name="pmid12471589">{{cite journal| author=Jenny-Avital ER, Abadi M| title=Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. | journal=Clin Infect Dis | year= 2002 | volume= 35 | issue= 12 | pages= e128-33 | pmid=12471589 | doi=10.1086/344467 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12471589  }} </ref><ref name="pmid10225395">{{cite journal| author=Blanche P, Gombert B, Ginsburg C, Passeron A, Stubei I, Rigolet A et al.| title=HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy. | journal=Scand J Infect Dis | year= 1998 | volume= 30 | issue= 6 | pages= 615-6 | pmid=10225395 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10225395  }} </ref><ref name="pmid9727570">{{cite journal| author=Woods ML, MacGinley R, Eisen DP, Allworth AM| title=HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. | journal=AIDS | year= 1998 | volume= 12 | issue= 12 | pages= 1491-4 | pmid=9727570 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9727570  }} </ref>


This may result in worsening of the pre-existing condition. Despite this, the duration of starting [[antifungal]] therapy when [[HIV AIDS medical therapy|HAART]] has been initiated still remains unclear.<ref name="pmid20047480">{{cite journal| author=Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ et al.| title=Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. | journal=Clin Infect Dis | year= 2010 | volume= 50 | issue= 3 | pages= 291-322 | pmid=20047480 | doi=10.1086/649858 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20047480  }} </ref>
This may result in worsening of the pre-existing condition. Despite this, the duration of starting [[Antifungal drug|antifungal therapy]] when [[HIV AIDS medical therapy|HAART]] has been initiated still remains unclear.<ref name="pmid20047480">{{cite journal| author=Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ et al.| title=Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. | journal=Clin Infect Dis | year= 2010 | volume= 50 | issue= 3 | pages= 291-322 | pmid=20047480 | doi=10.1086/649858 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20047480  }} </ref>


===Prognosis===
===Prognosis===
The mortality associated with fungal meningitis is high. Better prognosis is associated with early diagnosis, early initiation of the treatment and compliance of patients with medications.
The [[mortality]] associated with fungal meningitis is high. Better prognosis is associated with early diagnosis, early initiation of the treatment and compliance of patients with medications.
====Prognosis of cryptococcal meningitis====
====Prognosis of cryptococcal meningitis====
Prior to the introduction of [[amphotericin B]] therapy, [[Cryptococcal Meningitis|cryptococcal meningitis]] was almost always fatal. Now, although most of these patients can be cured with course of [[Intravenous therapy|intravenous]] [[amphotericin B]], the optimum duration of therapy is often unclear, and there is still a significant percentage of early deaths and late treatment failure.<ref name="pmid4811791">{{cite journal| author=Diamond RD, Bennett JE| title=Prognostic factors in cryptococcal meningitis. A study in 111 cases. | journal=Ann Intern Med | year= 1974 | volume= 80 | issue= 2 | pages= 176-81 | pmid=4811791 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4811791  }} </ref><ref name="pmid5054723">{{cite journal| author=Lewis JL, Rabinovich S| title=The wide spectrum of cryptococcal infections. | journal=Am J Med | year= 1972 | volume= 53 | issue= 3 | pages= 315-22 | pmid=5054723 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5054723  }} </ref><ref name="pmid13728643">{{cite journal| author=NEWCOMER VD, STERNBERG TH, WRIGHT ET, REISNER RM, McNALL EG, SORENSEN LJ| title=The treatment of systemic fungus infections with amphotericin B. | journal=Ann N Y Acad Sci | year= 1960 | volume= 89 | issue=  | pages= 221-39 | pmid=13728643 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13728643  }} </ref>
Prior to the introduction of [[amphotericin B]] therapy, [[Cryptococcal Meningitis|cryptococcal meningitis]] was almost always fatal. Now, although most of these patients can be cured with course of [[Intravenous therapy|intravenous]] [[amphotericin B]], the optimum duration of therapy is often unclear, and there is still a significant percentage of early deaths and late treatment failure.<ref name="pmid4811791">{{cite journal| author=Diamond RD, Bennett JE| title=Prognostic factors in cryptococcal meningitis. A study in 111 cases. | journal=Ann Intern Med | year= 1974 | volume= 80 | issue= 2 | pages= 176-81 | pmid=4811791 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4811791  }} </ref><ref name="pmid5054723">{{cite journal| author=Lewis JL, Rabinovich S| title=The wide spectrum of cryptococcal infections. | journal=Am J Med | year= 1972 | volume= 53 | issue= 3 | pages= 315-22 | pmid=5054723 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5054723  }} </ref><ref name="pmid13728643">{{cite journal| author=NEWCOMER VD, STERNBERG TH, WRIGHT ET, REISNER RM, McNALL EG, SORENSEN LJ| title=The treatment of systemic fungus infections with amphotericin B. | journal=Ann N Y Acad Sci | year= 1960 | volume= 89 | issue=  | pages= 221-39 | pmid=13728643 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13728643  }} </ref>
Line 38: Line 38:
*Hospitalization length
*Hospitalization length


'''Prognosis of coccidioidal meningitis'''
'''Prognosis of [[Coccidioidal Meningitis|coccidioidal meningitis]]'''


Prognosis is worst in patients with several sites of extrapulmonary dissemination compared to patients who have only [[meningeal]] involvement.<ref name="pmid8443303">{{cite journal| author=Vincent T, Galgiani JN, Huppert M, Salkin D| title=The natural history of coccidioidal meningitis: VA-Armed Forces cooperative studies, 1955-1958. | journal=Clin Infect Dis | year= 1993 | volume= 16 | issue= 2 | pages= 247-54 | pmid=8443303 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8443303  }} </ref>
Prognosis is worst in patients with several sites of extrapulmonary dissemination compared to patients who have only [[meningeal]] involvement.<ref name="pmid8443303">{{cite journal| author=Vincent T, Galgiani JN, Huppert M, Salkin D| title=The natural history of coccidioidal meningitis: VA-Armed Forces cooperative studies, 1955-1958. | journal=Clin Infect Dis | year= 1993 | volume= 16 | issue= 2 | pages= 247-54 | pmid=8443303 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8443303  }} </ref>
Prior to the introduction of [[antifungal]] therapy [[Coccidioidal Meningitis|coccidioidal]] meningitis was almost always fatal.<ref name="pmid8443303" />
Prior to the introduction of [[Antifungal drug|antifungal therapy]], [[Coccidioidal Meningitis|coccidioidal meningitis]] was almost always fatal.<ref name="pmid8443303" />


Factors associated with a bad prognosis of coccidiodal meningitis are:<ref name="pmid7231152">{{cite journal| author=Bouza E, Dreyer JS, Hewitt WL, Meyer RD| title=Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. | journal=Medicine (Baltimore) | year= 1981 | volume= 60 | issue= 3 | pages= 139-72 | pmid=7231152 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7231152  }} </ref>
Factors associated with a bad prognosis of [[coccidiodal meningitis]] are:<ref name="pmid7231152">{{cite journal| author=Bouza E, Dreyer JS, Hewitt WL, Meyer RD| title=Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. | journal=Medicine (Baltimore) | year= 1981 | volume= 60 | issue= 3 | pages= 139-72 | pmid=7231152 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7231152  }} </ref>
* [[Hydrocephalus]],
* [[Hydrocephalus]]  


* Non-caucasian race,
* Non-caucasian race


* Presence of an underlying disease
* Presence of an underlying disease

Revision as of 14:45, 4 April 2017

Meningitis main page

Fungal meningitis Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fungal meningitis from other Diseases

Epidemiology and Demographics

Screening

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

ECG

MRI

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Fungal meningitis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fungal meningitis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fungal meningitis natural history, complications and prognosis

CDC on Fungal meningitis natural history, complications and prognosis

Fungal meningitis natural history, complications and prognosis in the news

Blogs on Fungal meningitis natural history, complications and prognosis

Directions to Hospitals Treating Fungal meningitis

Risk calculators and risk factors for Fungal meningitis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby; Prince Tano Djan, BSc, MBChB [2]

Overview

If left untreated, neurological complications may occur. Fungal meningitis may be complicated by abscesses, bone invasion, fluid collections, neurological deficits, ocular invasion, papilledema, neurodevelopmental delays in children, and seizures[1][2][3][4][5] The mortality associated with fungal meningitis is high. Better prognosis is associated with early diagnosis, early initiation of the treatment and compliance of patients with medications.

Natural History, Complications and Prognosis

Natural History

If left untreated, neurological complications may occur.

Complications

The following are some complications that may follow fungal meningitis:[2][3][4][5]

Complications from therapy

Treatment of fungal meningitis in HIV-infected patients receiving HAART, organ transplantation, and pregnancy may result in immune reconstitution syndrome.[6][7][8][9]

This may result in worsening of the pre-existing condition. Despite this, the duration of starting antifungal therapy when HAART has been initiated still remains unclear.[10]

Prognosis

The mortality associated with fungal meningitis is high. Better prognosis is associated with early diagnosis, early initiation of the treatment and compliance of patients with medications.

Prognosis of cryptococcal meningitis

Prior to the introduction of amphotericin B therapy, cryptococcal meningitis was almost always fatal. Now, although most of these patients can be cured with course of intravenous amphotericin B, the optimum duration of therapy is often unclear, and there is still a significant percentage of early deaths and late treatment failure.[11][12][13]

The mortality of cryptococcal meningitis is high (10-30%).[14]

Increasing levels of the following worsens the prognosis of HIV-negative cryptococcal meningitis patients with acute/subacute onset;

Prognosis of coccidioidal meningitis

Prognosis is worst in patients with several sites of extrapulmonary dissemination compared to patients who have only meningeal involvement.[15] Prior to the introduction of antifungal therapy, coccidioidal meningitis was almost always fatal.[15]

Factors associated with a bad prognosis of coccidiodal meningitis are:[16]

  • Non-caucasian race
  • Presence of an underlying disease

References

  1. ↑ 1.0 1.1 John Marx. Chapter 107. Central Nervous System Infections. Marx: Rosen's Emergency Medicine, 7th ed. Mosby: Elsevier; 2009.
  2. ↑ 2.0 2.1 Farrugia MK, Fogha EP, Miah AR, Yednock J, Palmer HC, Guilfoose J (2016). "Candida meningitis in an immunocompetent patient detected through (1→3)-beta-d-glucan". Int J Infect Dis. 51: 25–26. doi:10.1016/j.ijid.2016.08.020. PMID 27590564.
  3. ↑ 3.0 3.1 Nyazika TK, Hagen F, Machiridza T, Kutepa M, Masanganise F, Hendrickx M; et al. (2016). "Cryptococcus neoformans population diversity and clinical outcomes of HIV-associated cryptococcal meningitis patients in Zimbabwe". J Med Microbiol. 65 (11): 1281–1288. doi:10.1099/jmm.0.000354. PMID 27638836.
  4. ↑ 4.0 4.1 Leonhard SE, Fritz D, van de Beek D, Brouwer MC (2016). "Cryptococcal meningitis complicating sarcoidosis". Medicine (Baltimore). 95 (35): e4587. doi:10.1097/MD.0000000000004587. PMC 5008555. PMID 27583871.
  5. ↑ 5.0 5.1 Neo WL, Durisala N, Ho EC (2016). "Reversible hearing loss following cryptococcal meningitis: case study". J Laryngol Otol. 130 (7): 691–5. doi:10.1017/S002221511600801X. PMID 27210482.
  6. ↑ Singh N, Perfect JR (2007). "Immune reconstitution syndrome associated with opportunistic mycoses". Lancet Infect Dis. 7 (6): 395–401. doi:10.1016/S1473-3099(07)70085-3. PMID 17521592.
  7. ↑ Jenny-Avital ER, Abadi M (2002). "Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy". Clin Infect Dis. 35 (12): e128–33. doi:10.1086/344467. PMID 12471589.
  8. ↑ Blanche P, Gombert B, Ginsburg C, Passeron A, Stubei I, Rigolet A; et al. (1998). "HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy". Scand J Infect Dis. 30 (6): 615–6. PMID 10225395.
  9. ↑ Woods ML, MacGinley R, Eisen DP, Allworth AM (1998). "HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection". AIDS. 12 (12): 1491–4. PMID 9727570.
  10. ↑ Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ; et al. (2010). "Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america". Clin Infect Dis. 50 (3): 291–322. doi:10.1086/649858. PMID 20047480.
  11. ↑ Diamond RD, Bennett JE (1974). "Prognostic factors in cryptococcal meningitis. A study in 111 cases". Ann Intern Med. 80 (2): 176–81. PMID 4811791.
  12. ↑ Lewis JL, Rabinovich S (1972). "The wide spectrum of cryptococcal infections". Am J Med. 53 (3): 315–22. PMID 5054723.
  13. ↑ NEWCOMER VD, STERNBERG TH, WRIGHT ET, REISNER RM, McNALL EG, SORENSEN LJ (1960). "The treatment of systemic fungus infections with amphotericin B." Ann N Y Acad Sci. 89: 221–39. PMID 13728643.
  14. ↑ Van der Horst CM, Saag MS, Cloud GA et al. (1997) Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med, 337, 15–21.
  15. ↑ 15.0 15.1 Vincent T, Galgiani JN, Huppert M, Salkin D (1993). "The natural history of coccidioidal meningitis: VA-Armed Forces cooperative studies, 1955-1958". Clin Infect Dis. 16 (2): 247–54. PMID 8443303.
  16. ↑ Bouza E, Dreyer JS, Hewitt WL, Meyer RD (1981). "Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature". Medicine (Baltimore). 60 (3): 139–72. PMID 7231152.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Fungal_meningitis_natural_history,_complications_and_prognosis&oldid=1304608"